2m 2m 2m 2m 2m 2m 2m
AVALO THERAP (AVTX)
NASDAQ
$16.20+$0.08 (+0.49%)
Price as of Sep 11, 2026 7:30 PM EDT- $864.5MMarket Cap
- 51.29%1-Year Change
- BiotechnologyIndustry
AVALO THERAP (AVTX)
$16.20+$0.08 (+0.49%)
AVTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $16.12 | ||
Change | -$1.06 (-6.17%) | ||
Open | $17.42 | ||
High | $18.14 | ||
Low | $16.02 | ||
Previous Close | $17.18 | ||
Volume | 2,525,470 | ||
30-Day Average Volume | 820,501 | ||
1-Week Change | -16.17% | ||
1-Month Change | -17.21% | ||
1-Year Change | 51.29% | ||
3-Year Change | -20.89% | ||
5-Year Change | -99.79% | ||
Fundamentals | |||
Shares Outstanding | 53.6M | ||
Total Assets | $490.8M | ||
Market Cap | $864.5M | ||
Enterprise Value | $779.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$36.4M | ||
Free Cash Flow | -$20.0M | ||
EBIT | -$36.3M | ||
EBITDA | -$36.3M | ||
Net Working Capital | $386.8M | ||
EPS | -$0.83 | ||
Enterprise Value/EBITDA | -21 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -19 | ||
PEG | -1 | ||
Price/Free Cash Flow | -43 | ||
Price/Operating Cash Flow | -43 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 240 | ||
Last Split Date | 12/29/2023 | ||
Earnings & Revenue